US NEUROLOGY – VOLUME 13 ISSUE 1 – SPRING 2017

Welcome to the latest edition of US Neurology, which features a wide range of articles that reflect the rapid pace of progress in neurology. We begin with two review articles on the subject of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) a challenging condition as it can mimic other neuropathies and can lead to chronic disability if […]

I am delighted to take on the role of Editor-in-Chief for European Neurological Review and would like to introduce myself. I studied medicine in Boston University, US, and specialised in neurology in Philadelphia. I then moved to Europe and worked on multiple sclerosis (MS) in Switzerland for two years. For the past 17 years, I […]

As its mission states, the American Epilepsy Society (AES) is working to eradicate epilepsy and its consequences. While this lofty goal may not yet be visible on the horizon, researchers and physicians who treat patients with epilepsy are making progress, as evidenced by the research and latest practices presented at the AES 70th Annual Meeting, […]

The clostridial neurotoxins (CNTs) (tetanus toxin [TeNT] and seven serologically distinct botulinum neurotoxins [BoNT/A–BoNT/D]), are among the deadliest agents known. They are bacterial enzymes produced by anaerobic, spore-forming bacteria of the genus Clostridium. Each toxin is composed of a heavy chain (HC) and a light chain (LC) linked via a disulfide bond. CNTs bind to […]

Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an autoimmune demyelinating polyradiculoneuropathy characterized by chronically progressive weakness and impaired sensory function in the lower and upper extremities.1 Symptoms, which are progressive over at least 8 weeks, may include weakness of the arms and legs (both proximal and distal), loss of vibration and joint position sense, poor balance, […]

Chronic inflammatory demyelinating polyneuropathy (CIDP) is an acquired immune-mediated disease that evolves in a progressive or relapsing pattern over months to years. Although “typical” CIDP is characterized by symmetric proximal and distal motor and sensory deficits, it is now recognized that multifocal (asymmetric), distally predominant, pure sensory, and pure motor variants also fall within the […]

Duchenne muscular dystrophy (DMD), the most common and devastating type of muscular dystrophy,1 is characterised by the absence of the protein dystrophin, which causes premature muscle cell failure and leads to progressive muscle atrophy and loss. The condition is typically diagnosed at age 3–5 years when children start to show signs of physical disability including […]

Multiple sclerosis (MS) onset during childhood or adolescence follows a relapsing-remitting pattern, with a high early relapse frequency, and is associated with a risk for cognitive impairment and future physical disability. Acute management of relapses, modulation of chronic disease course, cognitive evaluations and strategies for academic modifications, and multidisciplinary team approaches to the management of […]

Dural arteriovenous fistulas (dAVF)s are unique to the neuraxis as the arteriovenous shunt site is contained within the dural leaflets. They may be discovered incidentally or in a workup of a variety of potential neurological sequelae, including pulsatile tinnitus, ocular symptoms, focal neurologic deficits as a result of venous hypertension or even intracranial hemorrhage.1–7 Symptoms […]